Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03815890
Title Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO (BELLINI)
Acronym BELLINI
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
NKI-AVL RECRUITING Amsterdam 1066CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field